This inventor holds 4 USPTO granted patents, plus 1 CIPO patent. Top assignee: Merck + Co., Inc.. Active years: 1980-2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Plainsboro, NJ (US) (1980)
- New York, NY (US) (1985)
- Maplewood, NJ (US) (1990 - 2004)
Company Filing History:
Years Active: 1980-2004
Title: The Innovative Contributions of Jonathan A. Tobert
Introduction
Jonathan A. Tobert is a notable inventor based in Maplewood, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the area of cardiovascular health. With a total of 4 patents to his name, Tobert's work has had a meaningful impact on medical treatments.
Latest Patents
Tobert's latest patents include groundbreaking methods for reducing the risks associated with cardiovascular disease. One of his inventions provides methods for preventing or reducing the risk of developing atherosclerosis. This invention involves the administration of a therapeutically effective amount of an HMG-CoA reductase inhibitor in combination with folic acid or a pharmaceutically acceptable salt or ester thereof. This method is aimed at individuals who are at risk of developing atherosclerosis or who already have atherosclerotic disease. Another significant patent focuses on the use of Coenzyme Q10 with HMG-CoA reductase inhibitors. This pharmaceutical composition and method aim to counteract elevated transaminase levels associated with HMG-CoA reductase inhibitors through adjunct administration.
Career Highlights
Throughout his career, Jonathan A. Tobert has worked with prominent companies in the pharmaceutical industry, including Merck & Co., Inc. and Michael S. Brown. His experience in these organizations has contributed to his expertise and innovative capabilities in developing effective medical treatments.
Collaborations
Tobert has collaborated with esteemed colleagues such as Edward J. Cragoe, Jr. and Ralph F. Hirschmann. These partnerships have likely enhanced his research and development efforts, leading to the successful creation of his patents.
Conclusion
Jonathan A. Tobert's contributions to the field of cardiovascular health through his innovative patents demonstrate his commitment to improving medical treatments. His work continues to influence the pharmaceutical industry and offers hope for better health outcomes for individuals at risk of cardiovascular diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile